September 5, 2011
The Japanese Circulation Society (JCS) issued an “Urgent Statement on Antithrombotic Therapy in Atrial Fibrillation” aiming at proper use of the novel oral anticoagulant dabigatran on August 15. The statement “recommends” the use of dabigatran in non-valvular atrial fibrillation patients...read more